SecurAcath

For the Life of the Line

SecurAcath® is the only Subcutaneous Engineered Stabilization Device (ESD) that meets the 2016 Infusion Therapy Standards of Practice.

  • The new Standards state:

    - Subcutaneous ESDs have been successful in stabilizing PICCs and CVADs

    - Patient outcomes and patient and inserter satisfaction have been favorable

  • The Standards also include a new caution to be aware of the risk of
    adhesive-related skin injury (MARSI) associated with the use of adhesive-based ESDs
    

    - SecurAcath eliminates MARSI complications of adhesive-based ESDs

 

Dramatically Reduced Catheter Dislodgement

  • SecurAcath clinical data publications show very low catheter 
    rates of 0–1.5%
  • Adhesive securement devices have published dislodgement rates of 14–20%
  • Many accidental dislodgements occur during dressing changes when 
    is not secured
  • Decreased catheter replacement costs

    - PICC replacement cost is approximately $500 at bedside, $1000 in IR, $1200 in pediatrics

 

Decreased Catheter Movement

  • Catheter movement at the insertion site can introduce bacteria beneath the skin
  • Improved stability may promote healing at insertion site which acts as 
    natural barrier to infection
  • May reduce phlebitis, thrombosis and infection

 

Improved Efficiency

  • One SecurAcath secures for the life of the line
  • Catheter remains secure during dressing changes
  • Saves time during routine dressing changes

    - Dressing change can be done 3–5 minutes faster

  • Allows easy catheter repositioning if catheter tip must be pulled back

 

360 Degree Site Cleaning While Secured

  • Excellent cleaning access around the entire insertion site
  • Catheter remains stable and secure during cleaning
  • Improved stability and cleaning may help reduce infections

No Needle Sticks

  • Eliminates costly suture needlestick risk
  • Average cost of a needlestick injury is $825
  • There are over 92,000 suture needlestick injuries to healthcare 
    in the U.S. each year

 

Comfortable for Patients

  • Anchor sits in subcutaneous tissue, below pain receptor nerves
  • Patients in clinical study reported minimal pain or discomfort*

* data on file